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Summary: Sensory symptoms are generally not associated with Huntington’s disease 
(HD). We describe two patients with HD who had painful somatosensory symptoms. 
One patient also had auditory hallucinations. No other cause was found for these symp 
toms. Both patients also had significant depression and one patient committed suicide. 
Somatosensory symptoms may be a marker for depression in HD. Key Words: Hunting- 
ton’s disease-Somatosensory symptoms-Depression. 
Huntington’s disease (HD) is characterized by autosomal dominant inheritance of neu- 
ropsychiatric dysfunction, chorea, and other movement disorders. Sensory phenomena 
have not been associated with HD, although pathologic abnormalities have been docu- 
mented in the thalamus and posterior columns of HD cases (1-3). Somatosensory evoked 
potentials (SSEPs) are also abnormal in HD (4). In Bruyn and Went’s recent review of HD, 
sensory phenomena are not mentioned (5); Hayden, in his monograph, states that “there 
have been no reports of obvious sensory defects in Huntington’s chorea” (6). Folstein et 
al. have reported two patients with auditory hallucinations and interpreted these aural 
symptoms as the manifestation of an associated psychiatric disturbance (7). We have 
encountered two HD patients with signifcant somatosensory symptoms and no other 
evident explanation for the occurrence of these symptoms. One of these patients also had 
auditory hallucinations. These two patients represent a small fraction of the approximately 
150 HD patients seen in our movement disorders clinic over the past 8 years. 
CASE REPORTS 
Case 1 
This 42-year-old right-handed man whose mother, brother, sister, half-sister, and half- 
brother have documented HD first noted involuntary movements in mid 1983. Over the 
next 3 years his chorea progressed. His coordination and gait gradually deteriorated and by 
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mid 1986 he was no longer able to work as a janitor. He and family members denied 
cognitive changes. 
In mid 1986 he began to notice an unusual sensory disturbance. He described this as an 
intermittent “bee-sting feeling.” This sensation could occur on any part of his body, lasted 
for seconds to minutes, and was burning in quality. The discomfort was usually felt over an 
area -1 cm in diameter. Initially infrequent and mild in intensity, the discomfort worsened 
over the subsequent months. By early 1987 the pain had become intense and was occumng 
many times per hour. Trials of diphenhydramine, haloperidol, and amitriptyline failed to 
relieve the pain. 
He was initially seen at the University of Michigan Movement Disorders Clinic in Feb- 
ruary of 1987. Examination at that time revealed normal mental status except for a de- 
pressed affect. He  admitted to occasional suicidal ideation. Examination of cranial nerves 
revealed slowed optokinetic nystagmus and saccades, intermittant blepharospasm, oral- 
buccal-lingual chorea, and mild dysarthria. He had normal power and bulk in all muscles 
tested, rapid rhythmic alternating movements were slowed, and there was moderate chorea 
and dystonia involving all extremities, trunk, and neck. Sensation was intact to pain and 
light touch with questionable impairment of position and vibration sense. Deep tendon 
reflexes were 3 + and symmetric. Both plantars were flexor. 
His sensory symptoms continued to worsen and in March of 1987 he began to complain 
that the pain was so intense that he wished to end it by committing suicide. He was 
admitted to the inpatient psychiatric facility at the University of Michigan Medical Center 
for observation. He had a significant affective disturbance. Serum chemistries, complete 
blood count with differential, platelet count, serum folate and B,, levels, and thyroid 
function test results were normal. Nerve conduction studies, needle electromyography, 
and median nerve SSEPs were normal. Therapy was begun with carbamazepine, and on a 
dose of 200 mg p.0. t.i.d. (serum level 6.69; therapeutic range 4-8) he reported improve- 
ment in the intensity of his sensory symptoms, his affective disorder improved, and he was 
discharged. Several months later he continues to complain of his “bee-stings” but the 
intensity appears to be tolerable and his affective disorder has largely resolved. 
Case 2 
This 42-year-old female elementary school teacher whose paternal grandfather, father, 
paternal uncle, and sister had HD first developed sensory symptoms in the spring of 1973. 
At that time she developed an upper respiratory infection with coryza, hyperacusis, ver- 
tigo, malaise, arthralgias, and myalgias. The coryza resolved but the other complaints 
persisted. She also began to experience uncomfortable paresthesias in her extremities, and 
intermittent, sharp, shooting pains in her legs. Coincident with this illness she began to 
notice infrequent, low amplitude, “jerky,” involuntary movements of her extremities, and 
mild impairment of her ability to carry out fine coordinated movements. 
She was first seen in the University of Michigan Neurology Clinic in August of 1974. 
Examination at that time was normal. Trials of diazepam, indomethacin, and doxepin failed 
to produce improvement of her symptoms. Her sensory complaints spontaneously receded 
over the next two years. In 1976 her symptoms returned. She again complained of myal- 
gias, arthralgias, malaise, dysequilibrium, pain in her extremities, and hyperacusis. She 
was seen by several physicians and a diagnosis of polymyositis was made. A several-month 
course of prednisone did not relieve her symptoms. Her involuntary movements had grad- 
ually increased in frequency and amplitude from 1973 to 1976. She was treated with co- 
deine, propoxyphene, perphenazine/amitriptyline, diazepam, and thioridazine without any 
change in symptoms. 
She was seen in the Movement Disorders Clinic at the University of Michigan in Feb- 
ruary of 1980. She stated that her symptoms had progressively worsened over the past 4 
years. She also complained of difficulty with walking and some problems with her memory. 
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Mental status testing revealed deficits of memory, calculations, and orientation. Exami- 
nation of her cranial nerves showed slowed optokinetic nystagmus, and choreoathetoid 
movements of the tongue. Strength, tone, and muscle bulk were normal but there were mild 
choreoathetoid movements of all extremities and the trunk. Gait was narrow based with 
short, stuttering steps. Deep tendon reflexes were 3 + and plantars were flexor. Sensory 
examination revealed normal pain, temperature, light touch, and proprioception. Vibratory 
sense was minimally decreased in the lower extremities. Serial trials of phenytoin 300 
mg/day, haloperidol 5 mg b i d . ,  and thorazine 100 mg b i d .  failed to relieve her symptoms. 
Her auditory symptoms worsened and she began to complain of aural hallucinations. These 
would often awaken her from sleep and consisted of choirs singing the last thought she had 
before falling asleep. She also described hearing hymns and an unidentifiable voice repeat- 
ing her thoughts back to her. She continued to complain of severe, lancinating pain in- 
volving her extremities. She was admitted to the inpatient Neurology Service at the Uni- 
versity of Michigan Medical Center in July of 1980 for evaluation of her auditory and 
somatosensory symptoms. A psychiatric consultant believed that the patient had an affec- 
tive disorder. She was treated with amitriptyline, methadone. perphenazine, and ethchlor- 
vynol. Her auditory and somatosensory symptoms continued. Over the following months 
she continued to complain of considerable difficulty with the auditory hallucinations and of 
severe lower extremity pain. She committed suicide in July of 1982. 
Postmortem examination of her brain revealed no gross atrophy, but mild gliosis of the 
caudate nucleus was present on microscopic examination. No other gross or microscopic 
abnormalities were documented. 
DISCUSSION 
We have described two HD victims with prominent somatosensory symptoms. One of 
these patients also had auditory hallucinations. Both had significant affective disturbances 
and one committed suicide. One patient had sensory symptoms coinciding with the onset 
of chorea. In the other, the sensory complaints began months after the onset of chorea. In 
the absence of any other identifiable cause it seems likely that these sensory symptoms 
were secondary to HD. Thalamic and posterior column abnormalities have been noted in 
HD (1-3) although their prevalence within the HD population is unknown. However, the 
documented thalamic abnormalities are restricted to the ventrolateral thalamus and seem 
not to involve the posterior portions of the thalamus involved in the relay of somatosensory 
input (3). SSEPs are known also to be abnormal in HD and the degree of abnormality seems 
to correlate with clinical disease status (4). However, in our two patients, SSEPs were 
normal in the one patient in whom they were examined, and no thalamic changes were 
noted in the brain of the patient who came to autopsy. The latter finding does not exclude 
thalamic pathology because such changes may only be detectable by quantitative mor- 
phometry ( I ) .  
One feature common to both of these cases is that both patients had significant affective 
disorders. Folstein et al. have shown that affective disorders are quite common in HD (8,9). 
Affective symptoms may be an intrinsic feature of HD and not a reaction to chronic illness. 
Somatic symptoms may be a manifestation of depression and treatment of depression may 
relieve somatic symptoms (10). One patient had a positive response to carbamazepine. This 
agent is commonly employed in the treatment of neurogenic pain but may also have some 
efficacy in the treatment of affective disorders (1 1). The sensory symptoms experienced by 
these two patients may be either a manifestation of depression or an associated symptom 
secondary to another process causing both sensory symptoms and affective disorder. Re- 
gardless, we recommend that HD patients with significant sensory complaints be carefully 
monitored for the development of depression. 
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